The LADDER Trial
Genentech is again pursuing novel and creative ways to improve patient outcomes by testing long-term anti-VEGF delivery in the LADDER trial (Study of the Efficacy and Safety of the Ranibizumab…
Genentech is again pursuing novel and creative ways to improve patient outcomes by testing long-term anti-VEGF delivery in the LADDER trial (Study of the Efficacy and Safety of the Ranibizumab…
Tremendous Promise and Tragic Carelessness The excitement surrounding the potential for stem cell therapeutics in AMD, and many other diseases, in understandable. Great advances have been made in the last…